Sepsis Diagnostics Market Trends, Price, Revenue, Share, Growth and Forecast Until 2026 with Competition Tracking

Posted on 2018-07-27 by Mark Hub in Healthcare // 0 Comments

Fact.MR

Rockville, US, 2018-Jul-27 — /EPR Network/ — A fresh report has been added to the wide database of FactMR titled “Sepsis Diagnostics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026” gives an outlook of mannequin market value in 2017 and the expected scenario of Rate on Investment (ROI) with growing CAGR by the end of 2022. The report also studies the market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions during same stated forecast to 2022.

Request Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=391

According to a study by Fact.MR, the global sepsis diagnostics market is expected to witness strong growth, registering 7.7% CAGR during the forecast period 2017-2026. The global sepsis diagnostics market is also projected to generate US$ 707.3 million revenue by the end of 2026. Owing to the increase in scope and applications, significant growth is expected in the market. Moreover, early detection has been shown to be crucial for the better outcome of patients suffering from sepsis. Following are the insights on how the global sepsis diagnostics market will perform in the coming years.

6 Forecast Highlights on Global Sepsis Diagnostics Market

1- North America expected to emerge as the largest region in the global sepsis diagnostics market throughout the forecast period. By the end of 2026, North America is projected to exceed US$ 200 million revenue. Well-established healthcare infrastructure, the rise in adoption of advanced products is driving the growth of the market in the region. Moreover, septic poisoning is one of the leading causes of death in the U.S.

2- Europe and Asia Pacific Excluding Japan (APEJ) are also expected to witness significant growth in the coming years. Increasing mortality rate due to septic in APEJ is resulting in the immense opportunity for companies to introduce diagnostic tools and tests.

3- Assays & reagents are expected to witness strong growth throughout the forecast period. By the end of 2026, assays & reagents are estimated to bring in more than US$ 300 million revenue.

Browse Full Report with TOC- https://www.factmr.com/report/391/sepsis-diagnostics-market

4- Conventional diagnostics is expected to be the highly preferred method in sepsis diagnostics. Conventional diagnostics method is estimated to exceed US$ 400 million revenue towards the end of 2026.

5- Gram-positive bacterial sepsis is projected to witness the highest growth in the global sepsis diagnostics market. Gram-positive bacterial sepsis is estimated to create an absolute dollar opportunity of over US$ 100 million during 2017-2026.

6- Microbiology technology is expected to gain momentum in the global sepsis diagnostics market. By 2026 end, microbiology is estimated to bring in more than US$ 200 million revenue.

The report has also profiled leading companies in the global market for sepsis diagnostics, which will remain active through 2026. These include companies such as Biomérieux SA, Quidel Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Luminex Corporation, Abbott Laboratories, Inc., T2 Biosystems, Inc., Roche Holdings AG (Roche Diagnostics Limited), Danaher Corporation (Beckman Coulter, Inc.), Qiagen NV, Siemens Healthineers, and Abionic SA.

Buy this Report@ https://www.factmr.com/checkout/391/S

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick